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Pandoraea species have emerged as opportunistic pathogens among cystic fibrosis (CF) and
non-CF patients. Pandoraea pulmonicola is the predominant Pandoraea species among Irish CF
patients. The objective of this study was to investigate the pathogenicity and potential
mechanisms of virulence of Irish P. pulmonicola isolates and strains from other Pandoraea
species. Three patients from whom the P. pulmonicola isolates were isolated have since died. The
in vivo virulence of these and other Pandoraea strains was examined by determining the ability to
kill Galleria mellonella larvae. The P. pulmonicola strains generally were the most virulent of the
species tested, with three showing a comparable or greater level of virulence in vivo relative to
another CF pathogen, Burkholderia cenocepacia, whilst strains from two other species,
Pandoraea apista and Pandoraea pnomenusa, were considerably less virulent. For all Pandoraea
species, whole cells were required for larval killing, as cell-free supernatants had little effect on
larval survival. Overall, invasive Pandoraea strains showed comparable invasion of two
independent lung epithelial cell lines, irrespective of whether they had a CF phenotype.
Pandoraea strains were also capable of translocation across polarized lung epithelial cell
monolayers. Although protease secretion was a common characteristic across the genus, it is
unlikely to be involved in pathogenesis. In conclusion, whilst multiple mechanisms of pathogenicity
may exist across the genus Pandoraea, it appears that lung cell invasion and translocation
contribute to the virulence of P. pulmonicola strains.
INTRODUCTION
Pandoraea species are characterized as non-spore-forming,
catalase-positive, aerobic, Gram-negative rods with polar
flagella, and are often mistakenly identified as Burkholderia
cepacia complex (Bcc) or Ralstonia species (Schneider et al.,
2006; Stryjewski et al., 2003). At the time of writing, the genus
Pandoraea contains five described species, Pandoraea apista,
Pandoraea pulmonicola, Pandoraea pnomenusa, Pandoraea
sputorum and Pandoraea norimbergensis (Stryjewski et al.,
2003; Vandamme et al., 2000), which have been isolated
from patients with respiratory tract infections as well as from
soil, water and food (Schneider et al., 2006). Its closest
phylogenetic relative is the genus Burkholderia and, like
members of the genus Burkholderia, it has recently emerged as
a pathogen in the cystic fibrosis (CF) population. CF is a
genetically inherited disorder caused by mutations in the CF
transmembrane regulator (CFTR), a chloride channel. The
main source of morbidity and mortality for CF patients,
however, is the bacterial pathogens that they encounter
throughout their lives, including Pseudomonas aeruginosa
and, to a lesser extent, Bcc. Although Pandoraea species have
also been isolated from sputum samples of CF patients,
there is still very little known about their mechanisms of
pathogenicity or their roles in CF lung disease (LiPuma,
2003). In addition, Pandoraea isolates have been recovered
from both CF and non-CF patients from a variety of clinical
samples including blood, sputum, urine, the upper airways
and lung tissue (Pimentel & MacLeod, 2008). The recovery of
Pandoraea isolates from the blood of patients indicates that
Abbreviations: Bcc, Burkholderia cepacia complex; CF, cystic fibrosis;
CFS, cell-free supernatant; CFTR, cystic fibrosis transmembrane
regulator; FEV, forced expiratory volume; p.i., post-infection; TER,
transepithelial resistance.
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this organism is capable of invading tissue (Atkinson et al.,
2006; Stryjewski et al., 2003). Antibiotic therapy for infection
is difficult due to the limited number of antibiotics to which
these species are susceptible: tetracycline, imipenem and
trimethoprim–sulfamethoxazole (Schneider et al., 2006).
A systematic review of 102 publications has recommended
that CF patients colonized with either Pandoraea or Bcc
species should be segregated from other non-colonized
patients (Vonberg & Gastmeier, 2005). However, the
clinical significance of colonization with these organisms
remains unclear (Atkinson et al., 2006) and there are
limited and conflicting data available on the clinical
outcome of patients colonized with Pandoraea. Two CF
patients chronically colonized with P. apista were culture-
negative following post-bilateral transplants after antibiotic
therapy (Atkinson et al., 2006). However, apparent patient-
to-patient transmission of P. apista has been demonstrated,
and four of the patients exhibited a decrease in lung
function post-acquisition (Jørgensen et al., 2003). P.
pnomenusa sepsis and subsequent death has been reported
in a non-CF patient after a lung transplant (Stryjewski
et al., 2003). A recent case report highlighted nine previous
reports of Pandoraea bacteraemia, but only one of these
was identified as being in a CF patient (Pimentel &
MacLeod, 2008).
The predominant Pandoraea species among Irish CF
patients is P. pulmonicola. We have shown previously that
the Irish P. pulmonicola isolates were unusual within the
genus as they all showed an ability to invade human lung
epithelial A549 cells in vitro (Caraher et al., 2008). The
three patients from whom the P. pulmonicola isolates were
obtained have since died. Therefore, the virulence of these
P. pulmonicola isolates required further study. We
compared a selection of these isolates with other strains
in an in vivo virulence model, Galleria mellonella, and
also examined the interactions between some of these
P. pulmonicola isolates and lung epithelial cells in more
detail. The G. mellonella model was chosen as it has been
used previously to examine the virulence of a number of
CF pathogens including Bcc, Pseudomonas aeruginosa and
Aspergillus fumigatus (Kavanagh & Reeves, 2004; Reeves
et al., 2004; Seed & Dennis, 2008). The non-Irish strains
were all sourced from a commercial bacterial culture
collection and were all originally isolates from CF lung
(Table 1).
METHODS
Bacterial strains and cell lines. The origins of the Pandoraea
strains examined in this study are listed in Table 1. The non-Irish
isolates were purchased from the BCCM/LMG, University of Ghent,
Belgium. Non-invasive Escherichia coli strain NCIB 9485 was used as a
control in all experiments. All isolates were routinely grown on/in
tryptic soy agar, tryptic soy broth, Luria–Bertani (LB) agar or LB
broth at 37 uC. All cell lines were maintained in a humidified
atmosphere at 37 uC in 5% CO2. Calu-3 cells (sub-bronchial
epithelial cells) were obtained from the European Collection of Cell
Cultures and maintained as described previously (Shen et al., 1994).
The cell lines 16HBE14o2 (human bronchial epithelial cells with
functional CFTR) and CFBE41o2 (CF bronchial epithelial cells) were
kindly donated by Dr Dieter Gruenert (University of California, San
Francisco, CA, USA) and maintained in fibronectin/vitrogen-coated
flasks containing minimal essential medium supplemented with
5 mM L-glutamine, 50 U penicillin ml21, 50 mg streptomycin ml21
and 10% (v/v) fetal bovine serum.
Determination of virulence in vivo using G. mellonella larvae.
Sixth-instar larvae of G. mellonella were obtained from Livefoods
Direct and stored in wood shavings in the dark at 15 uC. Ninety
larvae (0.2–0.4 g each) were randomly chosen for each strain
assayed, and all experiments were performed on three independent
occasions. Bacterial cells were harvested by centrifugation at 4000 g
for 10 min and washed in PBS. The OD600 was obtained and cultures
were diluted to a standard of 0.1 OD600. Bacterial cultures were then
serially diluted to 1027. The bioburden was ascertained post-
injection by plate counts of dilutions from 1024 to 1027, plated in
triplicate. Ten larvae were inoculated with 20 ml each dilution
through the last pro-leg into the haemocoel using a 0.3 ml Myjector
syringe (Terumo Europe) and incubated in Petri dishes, on filter
paper, at 37 uC for 72 h in the dark. The control group consisted of
ten larvae injected with 20 ml sterile PBS. No more than one control
larva died in any given trial. In instances where more than one larva
died in the control group, the data from the entire experiment were
discarded. Larval death was followed for 72 h, at 24 h intervals, by
visual inspection and by the lack of movement when stimulated.
Three independent trials were conducted consisting of ten larvae per
bacterial concentration for each specified strain. Results are
presented as LD50 values, i.e. the inoculum concentrations that
resulted in 50% killing of the larvae in 72 h. Survival over time was
also monitored and plotted against the serially diluted bacteria (from
16100 to 16106 c.f.u.) and representative graphs of three
experiments are shown. To assess the virulence of cell-free
supernatant (CFS), bacterial cultures were pelleted by centrifugation
at 4000 r.p.m. in a microfuge for 10 min. Supernatants were then
passed through 0.22 mm pore filters to remove all bacteria. An
aliquot of 20 ml was injected into ten larvae. Sterile broth was used as
the control.
Invasion assay. The ability of Pandoraea strains to invade epithelial
cells was investigated as outlined previously (Caraher et al., 2008).
Lung epithelial cells (16HBE14o2 or CFBE41o2) were seeded on 24-
well plates (46105 cells per well) in medium containing 10% fetal
bovine serum, without antibiotics, and cultured for 24 h at 37 uC in
5% CO2. All bacterial strains were grown to an OD600 of 0.6 and
resuspended at the appropriate dilution, as determined by growth
curves, in tissue culture medium without antibiotics. These bacterial
suspensions were then added to the epithelial cells at an m.o.i. of 50,
as used previously. Intracellular invasion was determined over 2 h
following antibiotic killing of extracellular bacteria with 1 mg
amikacin ml21. The percentage invasion was determined as: (c.f.u.
recovered from lysed cells/c.f.u. applied to the cells)6100.
Measurement of transepithelial electrical resistance (TER).
Calu-3 cells were seeded onto Transwell polycarbonate inserts
(0.4 mm) and, after 1 day, the cells were maintained at an air–liquid
interface in order to promote differentiation (Foster et al., 2000). TER
was monitored for 14 days using an EVOM voltohmmeter (World
Precision Instruments) to ensure polarization and the formation of
tight junctions, and the cells were fed basolaterally on alternate days.
Prior to infection of the epithelial cells, each strain was grown to an
OD600 of 0.6 and 0.5 ml of the appropriate dilution of bacterial
suspension was added to the apical compartment and incubated at
37 uC. E. coli strain NCIB 9485 was used as a negative control. TER
was measured at 0, 1, 2 and 4 h post-infection (p.i.).
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Translocation studies. To examine the translocation of bacteria
through the epithelial monolayer, Calu-3 cells were seeded at a
density of 7.56105 cells per insert on 3.0 mm Transwell polycarbonate
inserts, a pore size that enables passage of the bacteria to the
basolateral chamber (Duff et al., 2006). The cells were cultured fed
basolaterally on alternate days for a period of up to 21 days. After
apical application of bacteria (m.o.i. 50), TER was monitored for up
to 3 h and the basolateral medium was sampled periodically and
serially diluted in Ringer’s solution to determine the c.f.u. ml21 that
translocated through the cell monolayer (Duff et al., 2006).
Protease activity assay. For detection of general protease secretion,
100 ml CFS from an overnight culture of each of the Pandoraea strains
was placed into wells on skimmed milk (3 and 10%, w/v) agar plates
containing nutrient agar. This method provides a convenient and
clear determination of protease detection on visual inspection and is
suitable for evaluating multiple bacterial strains simultaneously.
Sterile broth was used as a negative control and E. coli strain NCIB
9485 and Burkholderia cenocepacia strain BC7 were used as positive
controls. The plates were incubated at 37 uC for 24–48 h and any
zones of inhibition were measured (mm) using digital Vernier
callipers (Lennox Laboratory Supplies).
Statistical analysis. Dunn’s multiple comparison method was used
to compare the invasiveness of individual strains with that of the
negative control. A P value of ,0.05 was deemed to be significant in
each case. Student’s t-test was used to compare the TER values of
bacteria-treated monolayers relative to the control at individual time
points and apparent permeability coefficients, and also to compare
the percentage survival of G. mellonella at specific time points
following exposure to CFSs. In vivo virulence data for individual
strains were compared using one-way analysis of variance (Minitab).
RESULTS
Patients and isolates
Patient 1 was an adult female patient who was colonized
with P. pulmonicola at 36 years of age (isolate RL7177). She
was chronically colonized, and a second isolate (RL8228)
was obtained 9 months after the first isolate. Her forced
expiratory volume (FEV1) fell from 54% at the time of first
isolation of P. pulmonicola to 41% at the time of the
second isolation and continued to decline down to 21% at
44 months after the first P. pulmonicola isolation. Her
hospital admissions increased from a mean of 0.6 per year
prior to Pandoraea acquisition to 3 per year in the
subsequent 3 years. She died 52 months after her first
Pandoraea isolation, having spent the last 21 months as an
inpatient.
Patient 2 was an adult female who was colonized with P.
pulmonicola (RL0345) at 23 years of age. She was
chronically colonized and a second Pandoraea isolate was
obtained 8 months after the first isolation and identifica-
tion. Her FEV1 fell from 35 to 33% in the year prior to the
first isolation of P. pulmonicola, and dropped from 33 to
26% in the 12 months after P. pulmonicola isolation.
Although her hospital admissions did not change substan-
tially after acquisition of P. pulmonicola (2.5 per year in the
preceding years compared with 4 per year in the
subsequent 12 months), she died 14 months after the first
isolation of Pandoraea.
Patient 3 was also an adult female patient colonized with P.
pulmonicola (RL0308) at 19 years of age. Her hospital
admissions increased from a mean of 2 per year in the
3 years prior to Pandoraea isolation to 4 per year following
Pandoraea isolation. She had a lung transplant 5 months
after the first isolation of Pandoraea. Her FEV1 was 64% at
7 months post-transplant and decreased to 39% at
11 months post-transplant. She subsequently died 2 years
and 1 month after transplantation. Pandoraea was not
identified in this patient post-transplant.
P. pulmonicola strains are more virulent than
other Pandoraea species in vivo
We first examined the survival of G. mellonella larvae in
response to the four Irish clinical P. pulmonicola isolates
and to five other strains within the genus Pandoraea, and
Table 1. Summary of the origins of the Pandoraea strains and isolates used in this study and their relative LD50 values obtained in G.
mellonella larvae compared with that of B. cenocepacia strain J2315
LD50 is defined as the c.f.u. required to kill 50% of the G. mellonella larvae in 72 h. Data represent the mean of three independent trials with ten
larvae per group. ND, Not determined.
Species Strain Source LD50 (±SEM) at 72 h p.i.
P. pulmonicola RL7177 CF lung (Ireland, patient 1) 16104 (±8.76103)
RL8228 CF lung (Ireland, patient 1) 171 (±159)
RL0345 CF lung (Ireland, patient 2) 3.856105 (±71.56104)
RL0308 CF lung (Ireland, patient 3) 5.126105 (±3.86105)
LMG 18107 CF lung (USA) 1.54 (±1.0)
LMG 18108 CF lung (USA) 31.3 (±30)
P. apista LMG 16407 CF lung (Denmark) 8.86106 (±2.06105)
LMG 16408 CF lung (Denmark) 1.276106 (±4.46105)
P. pnomenusa LMG 18087 CF lung (UK) 5.26106 (±6.76105)
B. cenocepacia J2315 CF lung (USA) 4100 (±3412)
BC7 CF lung (USA) ND
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compared the results with values obtained for the B.
cenocepacia strain J2315. This Bcc strain was chosen as it
has been tested previously in a G. mellonella model (Seed &
Dennis, 2008). Although variability was observed across
the genus, there were clear species-specific effects on G.
mellonella survival. The four most virulent Pandoraea
strains, with the lowest LD50 at 72 h, were all P. pulmonicola
strains (Table 1). Four out of six P. pulmonicola strains
examined (RL7177, RL8228, LMG 18107 and LMG 18108)
were quite virulent and showed comparable or greater
virulence relative to that of B. cenocepacia strain J2315 (Table
1, P50.147). The fact that the four most virulent strains
included two patient isolates and two from a commercial
source indicated that this effect was not biased towards the
Irish clinical isolates or the commercially sourced isolates.
Both P. apista strains examined (LMG 16407 and LMG
16408) exhibited high LD50 values, indicating that they were
less virulent. The only P. pnomenusa strain examined also
had a high LD50 value. Interestingly, the two sequential P.
pulmonicola isolates (RL7177 and RL8228) obtained from
patient 1 showed a dramatic reduction in LD50 over time
between isolates, indicating that virulence had increased
with time.
The kinetics of killing varied across the genus. Individual P.
pulmonicola strains became more lethal with time following
the injection (Fig. 1a–c), whilst P. apista and P. pnomenusa
strains all had their optimal effect within 24 h with no
significant enhancement after that time (for example, P.
apista LMG 16408; Fig. 1d). All other P. pulmonicola strains
also showed this time-dependent effect (data not shown).
Cellular invasion of Pandoraea species is
independent of CF phenotype
We have shown previously that only a subset of Pandoraea
strains were capable of invading lung epithelial cells. Indeed,
the Irish P. pulmonicola strains were unusual in that the
majority of these were capable of invading A549 cells
(Caraher et al., 2008). To investigate the invasive potential of
the P. pulmonicola isolates further, we examined the
potential of a selection of these strains to invade lung
epithelial cells with and without a CF phenotype in order to
examine whether cells with a CF phenotype (CFBE41o2
cells) were more susceptible to invasion by members of this
genus relative to lung epithelial cells with functional CFTR
(16HBE14o2 cells). An m.o.i. of 50 was used as previous
studies have shown that invasion is optimal at this m.o.i.
Three clinical P. pulmonicola isolates that were found
previously to invade A549 cells (Caraher et al., 2008) were
selected, including the two sequential isolates (RL7177 and
RL8228) from one patient, to examine their potential to
invade these two distinct cell lines (16HBE14o2 and
CFBE41o2). These were compared with another strain
shown previously to be moderately invasive, P. pnomenusa
strain LMG 18087. Three Pandoraea strains (P. pulmonicola
RL0345 and RL8228, and P. pnomenusa LMG 18087)
were invasive in the 16HBE14o2 cells compared with the
negative-control E. coli strain NCIB 9485 (P,0.05 by
Dunn’s multiple comparison method in each case; Fig. 2).
The remaining isolate, P. pulmonicola RL7177, was classified
as non-invasive because the invasion values were not
significantly different from that of the control E. coli strain.
Only two of the Pandoraea isolates, P. pulmonicola RL0345
and RL8228, invaded CFBE41o2 cells (Fig. 2) when
compared with the negative-control E. coli (P,0.05). The
other two isolates, P. pnomenusa LMG 18087 and P.
pulmonicola RL7177, were not significantly more invasive
in CFBE cells than E. coli strain NCIB 9485. There was no
statistically significant difference in invasion of any strain
into CFBE41o2 cells versus 16HBE14o2 cells. Although
these cell lines are distinct, this study suggested that cells
with a CF phenotype are no more susceptible to invasion by
Pandoraea strains than those with functional CFTR.
Interestingly, a consistent increase in invasive potential in
the two sequential isolates, RL7177 and RL8228, in both
lung epithelial cell lines suggested that these strains had
become more invasive with time.
P. pulmonicola strains can translocate through
polarized lung epithelia
Pandoraea has been isolated from the blood of patients
(Atkinson et al., 2006; Daneshvar et al., 2001; Stryjewski
et al., 2003), but the majority of strains examined previously
were not invasive (Caraher et al., 2008). Therefore, we
wanted to examine whether Pandoraea strains were able to
invade through the lung epithelium from the apical to the
basolateral side. Calu-3 cells were grown as polarized
monolayers on filters with a pore size sufficiently large
(3 mm) to enable bacteria to pass through the filter to the
basolateral chamber. Although development of a tight
epithelium was slower than that observed for Calu-3 cells
when cultured on the smaller pore-size (0.4 mm) filters
(Duff et al., 2006), the TER peaked at 150 V cm22 over that
of blank filters on day 21. All experiments were carried out
on monolayers that had a TER of no less than 150 V cm22
above that of the control well. Bacterial counts from the
basolateral chamber indicated that all four strains examined
appeared to translocate within 3 h (Fig. 3a). The P. apista
strain LMG 16408 (shown previously to be non-invasive;
Caraher et al., 2008) was the slowest to translocate, reaching
levels in the basolateral chamber of 1% of bacteria (26105)
applied over the 3 h. During this time, all the other strains
appeared to translocate in excess of 16106 c.f.u. ml21. The
strain that translocated most readily was P. pnomenusa
strain LMG 18087.
To evaluate whether the observed translocation of
Pandoraea strains was mediated by disruption of tight
junctions, Calu-3 cells were grown on 0.4 mm Transwell
filters for 14 days, by which time the TER was routinely
greater than 1000 V cm22. The sequential P. pulmonicola
isolates RL7177 and RL8228 both resulted in a significant
drop in TER over time when applied to Calu-3 monolayers
relative to E. coli strain NCIB 9485 (P,0.015 for both
A. Costello and others
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strains; Fig. 3b). The two other strains that were shown to
translocate were P. pnomenusa LMG 18087 and P. apista
LMG 16408, but they did not cause a statistically significant
reduction in TER. We have shown previously that the
virulent CF pathogen B. cenocepacia strain BC7 disrupts
tight junction integrity in polarized Calu-3 cells (Duff
et al., 2006); therefore, this was included as a positive
control. The drop in TER following infection with the B.
cenocepacia strain BC7 was found to be comparable to that
of the P. pulmonicola isolates RL7177 and RL8228. The
TER at 4 h fell to 64±14% following infection with BC7
(excluded from Fig. 3b for clarity), compared with 59% for
RL7177 and 66% for RL8228.
Pandoraea isolates secrete proteases but these
are not involved in larval killing
Protease secretion by Pandoraea strains could play a role in
disruption of tight junctions or general lung tissue damage;
therefore, we wanted to determine the levels of protease
secretion in a selection of the clinical Irish isolates and
other strains. The protease activities of a range of
Pandoraea isolates were examined on 3 or 10% skimmed
milk agar plates together with those of E. coli NCIB 9485
and B. cenocepacia strain BC7, which were used as positive
controls in these studies (Gingues et al., 2005; Swamy &
Goldberg, 1982). All the Irish P. pulmonicola isolates
examined produced significant levels of protease activity.
This level was comparable to all other Pandoraea strains
examined and was also comparable to the levels of protease
activity of E. coli strain NCIB 9485 and B. cenocepacia strain
BC7 (Fig. 4).
The role of proteases in pathogenesis was examined by
injecting CFS from a series of Pandoraea isolates into G.
mellonella. In contrast to the killing of larvae by whole cells,
when CFS was administered to the larvae, no killing was
observed by Pandoraea strains examined up to 1 week post-
injection. This clearly indicated that, in general, cellular
components rather than secreted factors play a role in
100
80
60
40
20
0
100
80
60
40
20
0
100
80
60
40
20
0
100
80
60
40
20
0
100
107106105104103102101
107106105104103102101 108 100 107106105104103102101 108
108100 107106105104103102101 108100
RL8228
LMG 18108 LMG 16408
RL0345
S
ur
vi
va
l (
%
)
S
ur
vi
va
l (
%
)
S
ur
vi
va
l (
%
)
S
ur
vi
va
l (
%
)
c.f.u. per injection c.f.u. per injection
c.f.u. per injection c.f.u. per injection
(a) (b)
(c) (d)
Fig. 1. Kinetics of larval killing by Pandoraea strains. Survival of G. mellonella at 24 h ($), 48 h (#) or 72 h (.) following
infection with P. pulmonicola strains RL8228 (a), RL0345 (b) or LMG 18108 (c), or P. apista strain LMG 16408 (d). Each
dataset is from a single trial (n510), which was representative of three independent trials with the specified strain. The data are
presented as percentage larval survival from ten larvae injected per trial. No more than one control larva died in any given trial.
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killing among members of the genus Pandoraea. This
contrasted with the effects of CFS from B. cenocepacia
strain J2315 (Fig. 5a), which resulted in significant killing
of G. mellonella larvae within 72 h (70% survival).
Interestingly, in spite of the lack of effect on survival, the
CFS of certain strains, such as P. pulmonicola strains LMG
18107 and LMG 18108 and P. pnomenusa strain LMG
18087, had a reversible pathogenic effect on the larvae. The
larvae underwent melanization within 30 min (Fig. 5c) and
subsequently recovered without any effect on survival. This
melanization was never observed in the control larvae
injected with LB broth only (Fig. 5b). However, melaniza-
tion always preceded death of the larvae that were injected
with whole cells (Fig. 5d).
DISCUSSION
Pandoraea species are a relatively recently identified
pathogen among CF and non-CF patients (LiPuma, 2003;
Pimentel & MacLeod, 2008; Stryjewski et al., 2003).
Although Pandoraea has been isolated from the blood
and sputum samples of patients, very little is known about
its virulence or mechanisms of pathogenicity. P. pulmoni-
cola is the most commonly identified Pandoraea species
among Irish CF patients. However, there is very little
known about this species, in particular in terms of the
outcomes of infected patients or its pathogenicity. There-
fore we have focused, although not exclusively, on this
species. All three patients from whom P. pulmonicola was
isolated were female. This was an unavoidable bias in this
study, as there were not enough patients to allow a more
gender-balanced approach. In our experience, no gender
bias has been observed in Pandoraea colonization.
First, in order to compare the potential virulence of Pandoraea
species and strains, we evaluated nine strains in an in vivo
virulence model. The larvae of G. mellonella have been used
recently to evaluate a series of Bcc strains for their virulence
and their responses to phage therapies (Seed & Dennis, 2008,
2009). They have also been used to study the virulence of other
bacterial and fungal pathogens (Jander et al., 2000; Reeves
et al., 2004). The host response of G. mellonella to infection
shares many similarities with that of vertebrates (Kavanagh &
Reeves, 2004), making it a cheaper alternative to other in vivo
models. It has advantages over other in vivo models, such as
Caenorhabditis elegans, as Galleria larvae can survive at 37 uC.
The pattern of survival of G. mellonella following infection
with Pandoraea strains was species specific. Although the in
vivo studies were limited in that they were performed in a
single model, it was clear that the P. pulmonicola strains were
among the most virulent of the three species tested in this
model, with the other species, P. apista and P. pnomenusa,
being only weakly virulent (Table 1).
P. pulmonicola was also the species in which the majority of
strains displayed a potential for epithelial cell uptake
(Caraher et al., 2008). Therefore, in order to investigate
invasion further as a mechanism of virulence within these
Pandoraea strains, we compared invasion in cells with and
without a CF phenotype. Although the magnitude of
invasion into CFBE cells was less in general, the pattern of
invasion (i.e. invasive or not) of Pandoraea isolates into
both independent cell lines was comparable with invasion
of A549 cells. In particular, two of the Irish P. pulmonicola
isolates, RL0345 and RL8228, which showed considerable
invasive capacity of A549 cells, were also found to be
significantly invasive in both 16HBE14o2 and CFBE41o2
epithelial cell models. This demonstrates the ability of certain
Fig. 2. Comparison of invasion by Pandoraea
strains and the negative-control E. coli strain
NCIB 9485 in two lung epithelial cell lines,
16HBE14o” (black bars) and CFBE41o”
(grey bars). Results are shown as percentage
invasion (c.f.u. obtained after cell lysis as a
percentage of c.f.u. applied) of at least five
independent experiments for 16HBE14o”
cells and at least three independent experi-
ments for CFBE41o”, shown as means±SEM.
*, P,0.05 (invasion significantly greater than
that of E. coli, as determined by Dunn’s
multiple comparison test).
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Pandoraea isolates to invade three independent lung
epithelial cells and indicates that invasion is strain-specific
rather than cell-phenotype dependent. The lack of enhanced
susceptibility to invasion of cells with a CF phenotype over
non-CF cells agrees with a recent summary of nine Pandoraea
bacteraemia cases reported (Pimentel & MacLeod, 2008), at
least three of which were identified as being in non-CF
patients. The finding that P. pulmonicola isolate RL8228 was
both more invasive in human lung cells and more virulent to
larvae than the earlier isolate (RL7177) from the same patient
suggests that invasion plays a role in pathogenesis for some
members of the species. However, the finding that the two
other P. pulmonicola strains (LMG 18107 and LMG 18108)
were very virulent towards the larvae but were not shown
previously to be invasive indicates that other mechanisms of
pathogenicity are also at play.
In order to explore mechanisms of lung invasion further,
the ability of a selection of isolates to disrupt epithelial
integrity prior to entering the bloodstream was examined.
Human lung epithelial cells such as Calu-3 show
permeability properties that are comparable to those of
native lung epithelia and therefore are a useful model for
studying the absorption barrier of the lung (Forbes &
Ehrhardt, 2005). We and others have shown that Bcc
strains can disrupt the tight junction integrity of, and
penetrate through, lung epithelial monolayers (Duff et al.,
2006; Kim et al., 2005). Although all four Pandoraea
isolates tested had the ability to translocate through the
monolayer, albeit at different rates, two of the strains
examined translocated without having any effect on TER
(Fig. 3). This suggests that these pathogens move through
the monolayer via an alternative route to the paracellular
pathway.
Despite the diversity across the genus, all Pandoraea strains
tested secreted significant levels of protease and the three
Pandoraea species examined showed comparable protease
Fig. 3. Translocation of Pandoraea strains
through polarized Calu-3 epithelial mono-
layers. (a) Cumulative bacterial counts taken
from the basolateral chamber of Calu-3 cell
monolayers grown on 3 mm Transwell filters at
1, 2 and 3 h after infection with Pandoraea
strains expressed as total c.f.u. translocated
ml”1. The results are the means±SEM from at
least two independent experiments. (b) Effect
of Pandoraea strains on TER at 0, 1, 2 and 4 h
p.i., presented as the percentage of the E. coli
control (1092±225) and representing the
means±SEM of at least three independent
experiments.
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activities. Bacterial proteases have been implicated in a
number of pathogenic processes, including disruption of
epithelial integrity, inflammation and tissue damage.
However, the lack of effect of CFS in the in vivo model
suggested that secreted proteases, in general, may not play a
major role in pathogenesis. Furthermore, the lack of
correlation between protease activity and tight junction
disruption suggested that proteases are not likely to be
responsible for this effect. In contrast, members of the
closely related Bcc and also Peudomonas aeruginosa express
metalloproteases, which have been shown to be involved in
virulence (McKevitt & Woods, 1984; Kooi et al., 2006). In
addition, serine proteases have been identified in B.
cenocepacia, but, although one of these has been shown
to play a role in iron acquisition, their roles in
pathogenicity have not been confirmed (Flannagan et al.,
2007; Whitby et al., 2006). The relatively high level of
general protease secretion across the genus is interesting,
and the identity of these proteases is currently being
investigated. It remains a possibility that specific proteases
may play a role in the virulence of Pandoraea species.
Overall, the lack of effect of CFS on G. mellonella survival
for any species within the genus indicates that the whole
cells are the main mediator of virulence rather than
secreted exoproducts, strengthening the suggestion for
direct interaction between the bacterial cells and the host
cells as part of the virulence process.
This study showed that the genus Pandoraea is quite
divergent in terms of virulence characteristics; indeed, it
was named for the potential Pandora’s box of genetic
diversity associated with these organisms (Vandamme
et al., 2000). In general, P. pulmonicola strains are the
most invasive, and the majority of strains from this species
also showed the most virulence in the in vivo model.
However, to the best of our knowledge, there have been no
reported cases of P. pulmonicola-related bacteraemia.
Given the small numbers involved, it was difficult to
correlate in vitro behaviour with the clinical outcome in
patients; however, it is significant that all P. pulmonicola-
colonized patients from which the isolates in this study
were obtained have since died. Further studies will be
required with a greater number of isolates to draw any
definite conclusions.
The P. apista strains examined showed the lowest virulence
in G. mellonella, were non-invasive and P. apista strain LMG
16408 was the slowest to translocate across the polarized
lung epithelium. However, this species has been associated
with at least two cases of septicaemia (Daneshvar et al., 2001;
Johnson et al., 2004). Only one P. pnomenusa strain, LMG
18087, was included in this study and, although invasive in
lung cells expressing CFTR, it was not invasive in cells with a
CF phenotype. This strain showed the greatest level of
transepithelial translocation among the four isolates exam-
ined. Interestingly, four cases of P. pnomenusa-associated
bacteraemia have been reported (Daneshvar et al., 2001;
Stryjewski et al., 2003). Indeed, all three isolates identified as
P. pnomenusa by Daneshvar et al. (2001) were isolated from
blood, which led the authors to suggest that this species
might have increased potential for invasive disease. The
mechanism of P. pnomenusa translocation is not linked to
Fig. 4. Protease secretion from Pandoraea
species as determined on skimmed milk agar
plates. Bars represent zones of clearance
(±SD) measured following 48 h incubation of
Pandoraea cell CFS on 3% (black bars) or
10% (grey bars) skimmed milk plates from
three independent experiments.
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tight junction opening; therefore, further analysis of this
species is warranted.
The changes in the sequential P. pulmonicola isolates RL7177
and RL8228 are noteworthy. The later isolate was more
invasive in lung epithelial cells and more virulent in larvae.
Furthermore, in our previous study, we demonstrated that
the early isolate, RL7177, was the only Pandoraea strain out
of 19 examined that was capable of biofilm formation
(Caraher et al., 2008), suggesting that this strain also
underwent a mucoid to non-mucoid change over time. This
change from a mucoid to a non-mucoid state has also been
observed in Bcc isolates from chronically infected patients
(Zlosnik et al., 2008), indicating that the same phenotype
change arises among P. pulmonicola isolates; however, more
sequential isolates would need to be studied to confirm this.
In addition, further studies of the existing sequential isolates
are being performed to elucidate the apparent alteration in
virulence over time.
Overall, it was clear that P. pulmonicola strains showed
comparable in vivo virulence to B. cenocepacia strain J2315
in this G. mellonella model. A subset of P. pulmonicola
strains were shown to invade lung epithelial cells irrespec-
tive of CF status, and the four strains examined showed the
potential to translocate across the lung epithelium. In
addition, although protease secretion was a common
feature among all strains examined, there is no clear
evidence to date that this may be a virulence mechanism in
this genus. It is likely that individual species within the
Fig. 5. Effect of CFS on survival of G. mellonella. (a) Bars represent the percentage survival of ten larvae at 24 (black bars), 48
(light-grey bars) and 72 (dark-grey bars) h. Each bar represents the mean±SEM of three independent experiments. *, P,0.05,
relative to LB-injected control group. (b–d) Effect of P. pulmonicola RL7177 CFS on G. mellonella larvae 30 min after injection
with tryptic soy broth only (control; b), 30 min after injection with CFS from LMG 18108 (c) and 48 h after injection with whole
cells, showing killed larvae among the melanized larvae (d).
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genus Pandoraea have the potential to express very dif-
ferent mechanisms of pathogenesis, as demonstrated by
differences in intracellular invasion, tight junction disrup-
tion and larval killing. This is comparable to the situation
in Bcc strains, which appear to use different virulence
mechanisms to compete for survival in different environ-
ments and hosts (Uehlinger et al., 2009). There are limited
clinical data published on Pandoraea infections, and the
numbers of isolates evaluated in this study were also
limited; therefore, it is difficult to draw clear conclusions
regarding the mechanisms of pathogenicity and the effects
on patients. In addition, major host-related factors are also
at play and, given that many Pandoraea-colonized patients
are also co-colonized with other pathogens, the interplay
between competing species must also be considered. How-
ever, it is clear that P. pulmonicola does contribute to the
deterioration of colonized patients and has a direct interac-
tion with lung epithelial cells.
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